IPD: The Pathway To A Well-Planned R&D Program

By Dr. Christelle Boileau, IPD solution lead at PharmaLex

Crafting a successful path from scientific discovery to market-ready product requires a meticulous approach that integrates research, development, and regulatory compliance. This journey, critical for pharmaceutical innovation, emphasizes the importance of Integrated Product Development (IPD). By aligning scientific breakthroughs with regulatory requirements, IPD not only streamlines the development process but also increases the chances of successful market entry.

Prior to implementing an IPD strategy, conducting a thorough gap analysis is crucial. This evaluation helps identify development needs and regulatory obligations, forming the basis for a strong development plan. From the initial Proof of Concept (PoC) stages to clinical trials and beyond, each phase requires strategic alignment and adherence to rigorous quality standards.

In this article, we explore the strategic necessities of IPD, highlighting key milestones from preclinical optimization to clinical trial readiness. By proactively addressing these milestones, innovators can navigate the complexities of product development with clear direction and confidence.